Technological scalability in practice: Oshen, Eyedentity and Redfaire

Technological scalability is the lens through which to read three concrete cases that tell how a prototype becomes an operational and commercial infrastructure. This article compares Oshen, Eyedentity and Redfaire to show production choices, integration into customer workflows and forms of capital that truly enable repeatable growth. Here you will find precise numbers, practical examples and concrete risks useful to founders, investors and operators who must decide between multiple expansion paths. The discussion centers on technological scalability as the core criterion for those decisions.

Technological scalability is the core decision criterion for expansion.

When production becomes the heart of technological scalability

Oshen was founded in 2022 and builds C-Star, marine robots 1.2 meters long. C-Star exploits wind and solar energy to navigate in open sea. The company raised €4.27 million to accelerate production. Previously it built 15 units in three years. Now it aims to produce 15 units every six weeks. This leap is possible thanks to standardized procedures. A technician can assemble a unit in less than 30 minutes. Declared objective: large-scale replicability.

The commercial push comes from institutional customers and operations in extreme conditions. Three C-Star crossed the eye of Hurricane Humberto in September 2025, when the storm was Category 5. The data collected were used in bulletins of the United States National Hurricane Center. Oshen also has a €2.3 million project to deploy a constellation of 50 C-Star in the North Atlantic Subpolar Gyre. The purpose is to build an early warning system for a possible climatic tipping point. These figures show that logistics and the supply chain have become the real scaling constraint, no longer the sensor.

Production replicability and logistics are today the main constraints on growth.

Integrating technology into existing workflows reduces friction and speeds adoption

Eyedentity was founded in 2025 and raised €1.3 million, i.e. SEK 15 million, to commercialize a platform that analyzes fundus images already acquired by opticians. SEK is the Swedish krona. The value proposition is pragmatic: instead of asking opticians for new machines, Eyedentity receives existing images. The company processes them with artificial intelligence and flags which patients to refer to specialists. The company claims to reduce false referrals by 90%, meaning many fewer people sent unnecessarily to hospitals. No new hardware is required for the opticians.

Using existing data avoids creating new hardware channels.

Channel strategy is significant for those scaling healthcare software. Eyedentity runs a live pilot with Synologen, a network of opticians. The company aims to integrate its platform with electronic health record systems. The goal is to reach zero clicks for the optician. This approach recalls the logic of Redfaire, which since 2003 has provided ERP and cloud services and today counts over 200 employees. Redfaire inserts itself into clients’ critical processes to make itself indispensable. In both cases, working inside existing workflows reduces the need for training and speeds adoption.

Integrating technology into existing processes accelerates operational adoption.

Capital, governance and network choices that multiply scale

The capital raised is not just money, it changes market access and governance. Redfaire obtained €13 million from BGF, an investor with €250 million to invest and a history of over €4.67 billion of allocated capital across its portfolio. BGF also brings growth tools like the talent program that brought Glenn Timms as Non-Executive Chair. The presence of experts facilitates acquisitions and international scaling. Such an investor eases expansion and cross-border operations. An investor brings commercial access and regulatory expertise.

For Oshen, the round led by Lunar Ventures supports a production leap. These funds respond to requests from entities like NOAA, the Royal Navy and the Met Office. The United States Naval Meteorology and Oceanography Command is also interested. These customers open commercial channels but require compliance and resilience. For Eyedentity, support from Norrsken Launcher and the Karolinska Institutet incubator adds clinical credibility. This support opens paths toward regulatory approval. Therefore, when choosing capital, ask whether the investor brings commercial access, regulatory expertise or operational networks beyond liquidity.

Choose investors who provide market access and governance.

Practical risks and operational moves to turn prototypes into infrastructure

There are concrete and manageable risks. For Oshen the key question is logistical sustainability. Replicating 15 units every six weeks across multiple sites requires redundant supply chains. A maintenance plan is also needed for fleets that remain at sea for months. For Eyedentity the risk is regulatory and statistical. Clinical data sufficient to confirm that the 90% reduction in false positives holds across larger populations are required. For Redfaire the risk is integration after acquisitions such as that of eKal Solutions. The new capacity in human capital management and financial performance must be absorbed without interrupting customer services.

Three operational moves for those who want to scale: first, document and standardize operations until cycle times become repeatable. Oshen shows that clear procedures allow assemblies in less than 30 minutes. Second, integrate the product into existing touchpoints. Eyedentity demonstrates that using images already acquired by opticians avoids creating new channels. Third, select capital that provides market access and governance, not just liquidity. Redfaire benefits from strategic support and network. Documenting operations reduces cycle times and increases predictability. The open challenge is to demonstrate sustainability and value in real conditions while scaling.

Document and standardize operations until cycle times are repeatable.

Sources:

• Plymouth-based Oshen raises €4.27 million to scale robot swarms… | eu-startups.com
• Stockholm-based Eyedentity secures €1.3 million to detect deadly… | eu-startups.com
• Limerick-based Redfaire lands €13 million from BGF to scale its ERP… | eu-startups.com